Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Notes from the Field: Mycobacterium chimaera Contamination of Heater-Cooler Devices Used in Cardiac Surgery — United States

Weekly / October 14, 2016 / 65(40);1117–1118


Article Metrics

Views equals page views plus PDF downloads

Views:

Citations:

Altmetric:

Metric Details

Kiran M. Perkins, MD1; Adrian Lawsin, MS1; Nabeeh A. Hasan, PhD2; Michael Strong, PhD2; Alison L. Halpin, PhD1; Rachael R. Rodger, MPH2; Heather Moulton-Meissner, PhD1; Matthew B. Crist, MD1; Suzanne Schwartz, MD3; Julia Marders,  MS3; Charles L Daley, MD2; Max Salfinger, MD2; Joseph F. Perz, DrPH1 (View author affiliations)

View suggested citation

In the spring of 2015, investigators in Switzerland reported a cluster of six patients with invasive infection with Mycobacterium chimaera, a species of nontuberculous mycobacterium ubiquitous in soil and water. The infected patients had undergone open-heart surgery that used contaminated heater-cooler devices during extracorporeal circulation (1). In July 2015, a Pennsylvania hospital also identified a cluster of invasive nontuberculous mycobacterial infections among open-heart surgery patients. Similar to the Swiss report, a field investigation by the Pennsylvania Department of Health, with assistance from CDC, used both epidemiologic and laboratory evidence to identify an association between invasive Mycobacterium avium complex, including M. chimaera, infections and exposure to contaminated Stöckert 3T heater-cooler devices, all manufactured by LivaNova PLC (formerly Sorin Group Deutschland GmbH) (2). M. chimaera was described as a distinct species of M. avium complex in 2004 (3). The results of the field investigation prompted notification of approximately 1,300 potentially exposed patients.* Although heater-cooler devices are used to regulate patients’ blood temperature during cardiopulmonary bypass through water circuits that are closed, these reports suggest that aerosolized M. chimaera from the devices resulted in the invasive infections (1,2). The Food and Drug Administration (FDA) and CDC have issued alerts regarding the need to follow updated manufacturer’s instructions for use of the devices, evaluate the devices for contamination, remain vigilant for new infections, and continue to monitor reports from the United States and overseas (2).

Whole genome sequencing was completed on isolates from 11 patients and from five Stöckert 3T heater-cooler devices from hospitals in Pennsylvania and Iowa, two of the states where clusters of infections were identified (2). Samples from heater-cooler devices included swabs from the interior of the device, water drained from the devices, and air samples collected while a device was operating. Single nucleotide polymorphisms (SNPs) were identified after comparing patient and device samples against sequence data from an M. chimaera reference isolate. Results from pairwise comparisons among all sequences across a core genome of approximately 5 million base pairs revealed a maximum of 38 SNPs between any two isolates related to the outbreak investigation, versus a minimum of 2,900 SNPs between any single outbreak isolate and the epidemiologically unlinked isolate (sequence files available from the National Center for Biotechnology Information: Pennsylvania isolates Bioproject PRJNA344472; Iowa isolates Bioproject PRJNA345021; epidemiologically unlinked isolate RefSeq Assembly Accession GCF_001307335.1).

These results strongly suggest a point-source contamination of Stöckert 3T heater-cooler devices with M. chimaera. A recent report from Germany noted that preliminary typing results of M. chimaera from heater-cooler devices from three different European countries were almost identical to samples obtained from the manufacturing site, further supporting the likelihood of point-source contamination (4). Additional sequence comparisons between patient specimens and device samples obtained from facilities from various regions in the United States are ongoing. Sequence comparisons between U.S. and European samples, as well as samples from the manufacturing site, could provide additional information for evaluating the possibility of point-source contamination at the heater-cooler manufacturing site. Efforts are currently ongoing to obtain and compare European sequencing results.

Although thousands of patients in the United States have been notified regarding potential exposure to contaminated heater-cooler devices, the number who were exposed might be much larger. Over 250,000 procedures using cardiopulmonary bypass are performed in the United States each year (5). Stöckert 3T heater-cooler devices represent approximately 60% of the U.S. market (2). CDC and FDA are continuing their efforts to increase provider and patient awareness of the risk. CDC has issued guidance on identifying patients at risk to ensure timely diagnosis and treatment of these indolent and often unrecognized infections (2). FDA is continuing to gather information, issue communications, and assess the situation from both public health and regulatory perspectives (6).†

Acknowledgments

Bette Jensen, MMSc, Shannon Keckler, PhD, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, CDC.

Corresponding author: Kiran M. Perkins, kperkins@cdc.gov, 404-639-1161.

1Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, CDC; 2National Jewish Health; 3Food and Drug Administration.


References

  1. Sax H, Bloemberg G, Hasse B, et al. Prolonged outbreak of Mycobacterium chimaera infection after open-chest heart surgery. Clin Infect Dis 2015;61:67–75. CrossRef PubMed
  2. Food and Drug Administration. Nontuberculous mycobacterium (NTM) infections associated with heater-cooler devices (HCD) during cardiothoracic surgery. Gaithersburg, MD: FDA Circulatory System Devices Panel of the Medical Devices Advisory Committee; June 2–3, 2016. http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/CirculatorySystemDevicesPanel/ucm485091.htm
  3. Tortoli E, Rindi L, Garcia MJ, et al. Proposal to elevate the genetic variant MAC-A, included in the Mycobacterium avium complex, to species rank as Mycobacterium chimaera sp. nov. Int J Syst Evol Microbiol 2004;54(Pt 4):1277–85.
  4. Haller S, Höller C, Jacobshagen A, et al. Contamination during production of heater-cooler units by Mycobacterium chimaera potential cause for invasive cardiovascular infections: results of an outbreak investigation in Germany, April 2015 to February 2016. Euro Surveill 2016;21. PubMed
  5. The Society of Thoracic Surgeons. Adult cardiac surgery volumes and procedures. Adult Cardiac Surgery Database 2015. Chicago, IL: The Society of Thoracic Surgeons; 2016. http://www.sts.org/sts-national-database/database-managers/adult-cardiac-surgery-database
  6. Food and Drug Administration. Mycobacterium chimaera infections associated with Sorin Group Deutschland GmBH Stöckert 3T Heater-Cooler System: FDA Safety Communication. June 1, 2016. Washington, DC: US Department of Health and Human Services, Food and Drug Administration; 2016. http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm504213.htm

Suggested citation for this article: Perkins KM, Lawsin A, Hasan NA, et al. Notes from the Field. Mycobacterium chimaera Contamination of Heater-Cooler Devices Used in Cardiac Surgery — United States. MMWR Morb Mortal Wkly Rep 2016;65:1117–1118. DOI: http://dx.doi.org/10.15585/mmwr.mm6540a6.

Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.
References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.

All HTML versions of MMWR articles are generated from final proofs through an automated process. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (https://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables.

Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.

Format:
TOP
window.CDC.Policy.External.init();